Authors
Scott D. Newsome, DO, MSCS
Latest:
Age-Related Changes in Multiple Sclerosis Pathophysiology and Clinical FunctionUnderstanding age-related changes in multiple sclerosis (MS) may help inform treatment decisions that address normal aging and MS-related aging processes.
Mostafa Meshref, PhD, MSc
Latest:
The Emerging Role of Optogenetics in Multiple Sclerosis ResearchPossible future applications of optogenetics in MS therapy include the induction of oligodendrocyte proliferation, myelin synthesis, enhancing the repair of demyelinating processes, and modulating the severity of MS symptoms.
Jeff Wilken, PhD
Latest:
Comorbidity, Polypharmacy, and Aging in Multiple SclerosisComprehensive care addressing issues that are common in older people with MS, including polypharmacy and comorbidity, may improve quality of life, adherence, and overall health.